Poly (amino acid) micelle nanocarriers in preclinical and clinical studies
- 9 February 2008
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 60 (8), 899-914
- https://doi.org/10.1016/j.addr.2007.11.010
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Synergistic antitumor activity of the novel SN‐38‐incorporating polymeric micelles, NK012, combined with 5‐fluorouracil in a mouse model of colorectal cancer, as compared with that of irinotecan plus 5‐fluorouracilInternational Journal of Cancer, 2008
- A phase I and pharmacokinetic study of NK105, a paclitaxel-incorporating micellar nanoparticle formulationBritish Journal of Cancer, 2007
- Novel SN-38–Incorporating Polymeric Micelles, NK012, Eradicate Vascular Endothelial Growth Factor–Secreting Bulky TumorsCancer Research, 2006
- NK105, a paclitaxel-incorporating micellar nanoparticle, is a more potent radiosensitising agent compared to free paclitaxelBritish Journal of Cancer, 2006
- XELOX (Capecitabine Plus Oxaliplatin): Active First-Line Therapy for Patients With Metastatic Colorectal CancerJournal of Clinical Oncology, 2004
- Micellar Nanocontainers Distribute to Defined Cytoplasmic OrganellesScience, 2003
- Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancerThe Lancet, 1998
- Block copolymer micelles as vehicles for drug deliveryJournal of Controlled Release, 1993
- Polymer micelles as novel drug carrier: Adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymerJournal of Controlled Release, 1990
- Anti-tumour platinum complexes : relationships between chemical properties and activityBiochimie, 1978